Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21135532 | 0.94 | CA2 (0.50) | CA2LPAR1LPAR3LMNAPOLB | |
| SCHEMBL9080283 | 0.91 | CA2 (0.50) | CA2LPAR1LPAR3LMNAPOLB | |
| SCHEMBL8277024 | 0.90 | LPAR1 (0.51) | LPAR1LPAR3ENPP2 | |
| SCHEMBL31520002 | 0.90 | LPAR1 (0.51) | LPAR1LPAR3ENPP2 | |
| SCHEMBL6805094 | 0.90 | LPAR1 (0.51) | LPAR1LPAR3ENPP2 | |
| SCHEMBL5936343 | 0.90 | LPAR1 (0.51) | LPAR1LPAR3ENPP2 | |
| SCHEMBL13047224 | 0.90 | CA2 (0.47) | CA2LPAR1LPAR3LMNAPOLB | |
| SCHEMBL19301013 | 0.88 | CA2 (0.53) | CA2LMNAPOLB | |
| SCHEMBL2297204 | 0.87 | CA2 (0.49) | CA2LPAR1LPAR3LMNAPOLB | |
| SCHEMBL21135290 | 0.86 | CTDSP1 (0.47) | CTDSP1LPAR1LPAR3LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190194157-A1 | COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194157-A1 | COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES | ITCH, RNF168, DCTN1 | CA2 3668/4885CTDSP1 2457/4885LPAR1 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.